Interleukin Genetics, Inc.

Sheila E Francis

Gordon W Duff

David C Crossman

Kenneth S Kornman

Katherine Stephenson

Katherine Martinez

The kits and methods of the present invention relate to the diagnosis of cardiovascular disorders. In one aspect, the invention discloses a method and a kit for determining whether a subject has a fragile plaque disorder. In one aspect, the invention discloses a method and a kit for determining whether the subject has an occlusive disorder. In one aspect, the invention discloses a method and a kit for determining whether the subject has a restenosis disorder. Other methods of the present invention relate to the selection of therapeutics for a patient with a cardiovascular disease.

Method for diagnosing myocardial infarction

Methods and kits for determining whether a subject has or is predisposed to developing restenosis are provide.

Diagnostics and therapeutics for restenosis

Diagnostics for cardiovascular disorders

Methods and assays are disclosed for predicting a patient's risk for an inflammatory disorder such as coronary artery disease or related vascular disorders. The methods comprise obtaining a biological sample from a patient and determining the presence or absence of a particular allele which is linked with coronary artery disease. Detection of the allele is indicative of susceptibility to develop coronary artery disease. Kits for the detection of coronary artery disease are additionally provided, as are means for identifying additional alleles associated with coronary artery disease.

Growing community of inventors

Sheffield, United Kingdom

Sheila E Francis